Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge

Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml

Biphasic isophane insulin 30/70 injection (100iu/ml) , (r-dna origin) , 3ml cartridge,multivitamin

Inj. insulin degludec with insulin aspart

Insulin degludec (r-dna origin)100iu/ml in 3ml penfills

Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.

Biphasic isophane insulin injection 50 percent soluble & 50 percent isophane of 100iu per ml of 10ml vial

Insulin degludec (r- dna origin) solution for subcutaneous injection , 1 ml of solution contains 100 unit of insulin degludec equivalent to 3.66 mg , one prefilled pen contain 300 unit of insulin degludec in 03 ml solution in pfs

(ph no.:10018) 30 percent neutral insulin, 70 percent isophane insulin 100 iu/ml - 3 ml cartridges ( 1pen free for every 30 cartriges),unit:penfill

Insulin-mixtard 30/70 penfill -30 percent reguler +70 percent nph human nsulin